Bank of New York Mellon
TECX

Bank of New York Mellon’s Tectonic Therapeutic TECX Stock Holding History

Bank of New York Mellon’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$868K Buy
25,247
+487
+2% +$14.3K ﹤0.01% 3452
2026
Q1 		$765K Sell
24,760
-1,098
-4% -$27K ﹤0.01% 3374
2025
Q4 		$539K Sell
25,858
-275
-1% -$5.11K ﹤0.01% 3571
2025
Q3 		$410K Buy
26,133
+875
+3% +$18.1K ﹤0.01% 3708
2025
Q2 		$502K Buy
+25,258
New +$512K ﹤0.01% 3507
2024
Q1 		– Sell
-1,399
Closed -$22.8K – 4328
2023
Q4 		$22.8K Hold
1,399
– – ﹤0.01% 4228
2023
Q3 		$25.9K Hold
1,399
– – ﹤0.01% 4226
2023
Q2 		$15.9K Hold
1,399
– – ﹤0.01% 4309
2023
Q1 		$16.8K Hold
1,399
– – ﹤0.01% 4327
2022
Q4 		$12K Hold
1,399
– – ﹤0.01% 4406
2022
Q3 		$11K Hold
1,399
– – ﹤0.01% 4504
2022
Q2 		$15K Sell
1,399
-10,724
-88% -$126K ﹤0.01% 4524
2022
Q1 		$192K Sell
12,123
-284
-2% -$5.87K ﹤0.01% 4256
2021
Q4 		$573K Buy
12,407
+286
+2% +$16.4K ﹤0.01% 3717
2021
Q3 		$813K Buy
12,121
+2,358
+24% +$194K ﹤0.01% 3518
2021
Q2 		$1.04M Sell
9,763
-61,516
-86% -$7.29M ﹤0.01% 3390
2021
Q1 		$10.9M Buy
71,279
+6,816
+11% +$1.11M ﹤0.01% 2043
2020
Q4 		$10.8M Buy
64,463
+1,438
+2% +$256K ﹤0.01% 1962
2020
Q3 		$9.85M Buy
63,025
+1,559
+3% +$314K ﹤0.01% 1864
2020
Q2 		$12.9M Buy
61,466
+52,710
+602% +$10.9M ﹤0.01% 1683
2020
Q1 		$1.64M Buy
8,756
+804
+10% +$189K ﹤0.01% 2651
2019
Q4 		$1.92M Buy
7,952
+631
+9% +$122K ﹤0.01% 2843
2019
Q3 		$1.24M Buy
7,321
+3,151
+76% +$713K ﹤0.01% 3043
2019
Q2 		$814K Buy
4,170
+402
+11% +$86.7K ﹤0.01% 3338
2019
Q1 		$997K Buy
3,768
+1,607
+74% +$294K ﹤0.01% 3186
2018
Q4 		$431K Buy
2,161
+815
+61% +$248K ﹤0.01% 3562
2018
Q3 		$838K Buy
+1,346
New +$597K ﹤0.01% 3370

Other funds holding TECX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bank of New York Mellon's TECX Position: Q2 2026 in Review

Bank of New York Mellon increased its Tectonic Therapeutic (TECX) stake by 2% in Q2 2026, buying an estimated $14.3K and bringing the position to 25,247 shares worth $868K. The position accounts for ﹤0.01% of the portfolio, ranked #3452.

Bank of New York Mellon first reported a position in TECX in Q3 2018 and has held it in 27 quarters since. The position peaked at $12.9M in Q2 2020. 57 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Bank of New York Mellon held 25,247 shares of Tectonic Therapeutic worth $868K as of Q2 2026.
  • Bank of New York Mellon bought 487 Tectonic Therapeutic shares in Q2 2026, an estimated $14.3K.
  • Tectonic Therapeutic made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3452 holding.
  • Bank of New York Mellon first reported a position in Tectonic Therapeutic in Q3 2018 and has held it in 27 quarters since.
  • Bank of New York Mellon's Tectonic Therapeutic position peaked at $12.9M in Q2 2020.
  • 57 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.